PFIZER INC
8-K, 1999-11-12
PHARMACEUTICAL PREPARATIONS
Previous: SPARTECH CORP, S-3, 1999-11-12
 Next: PFIZER INC, 8-K, 1999-11-12

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
     

FORM 8-K
   
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934 
     
Date of report: November 12, 1999 
Date of earliest event reported: November 8, 1999
 
PFIZER INC.
(Exact name of registrant as specified in its charter) 
 
Delaware
(State or other jurisdiction of incorporation)
1-3619
(Commission File Number)
13-5315170
(I.R.S. Employer Identification No.)
 
235 East 42nd Street 
New York, New York 
(Address of principal executive offices)
 10017
(Zip Code)
 
Registrant's telephone number, including area code: 
(212) 573-2323 
 

 
 
 
 

Item 5. Other Events

Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of Pfizer Inc. dated November 8, 1999 relating to its current performance and outlook and its offer to acquire all of the outstanding shares of Warner-Lambert Company.

 
 

Item 7(c). Exhibits
99.1
 Press release of Pfizer Inc. dated November 8, 1999.
 

 
 

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

 
 
 

PFIZER INC.
Dated: November 12, 1999
 
 

By: /s/ MARGARET M. FORAN
Name: Margaret M. Foran 
Title: Vice President- Corporate Governance 

 
 
 
 
 
 

Index to Exhibits
99.1
 Press release of Pfizer Inc. dated November 8, 1999 relating to its current performance and outlook and its offer to acquire all of the outstanding shares of Warner-Lambert Company.
   
   

 
 
 
 
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission